Skip to main content

Table 1 Demographic and Clinical Characteristics of 139 patients Across Treatment Groups at Baseline

From: Efficacy of endoluminal interventional therapy in diabetic peripheral arterial occlusive disease: a retrospective trial

Characteristics

Diabetes group

(n = 62)

Non-diabetes group (n = 77)

Test

Statistics

P

Value

Age(years)

64.7 ± 11.0

65.2 ±9.8

-0.308

0.759

Male

37(59.7%)

49(63.6%)

0.228

0.633

history of tobacco

33(53.2%)

45 (58.4%)

0.379

0.538

hypertension

36(58.1%)

53 (68.8%)

1.729

0.189

coronary artery disease

19(30.6%)

21 (27.3%)

0.191

0.662

Treatment with insulin

45 (72.6%)

0 (0%)

Fisher's

exact test

0.000

Pre-operation ABI

0.396 ± 0.125

0.406 ± 0.101

0.113

0.910

Lesion location

    

Iliac artery

26(23.2%)

32(23.7%)

0.002

0.964

Femoral artery

51(45.5%)

61 (45.2%)

0.202

0.653

Popliteal artery

19(17%)

23(17%)

0.010

0.921

Tibial artery

16(14.3%)

19(14.1%)

0.023

0.879

Clinical symptom

    

claudication

14 (22.6%)

12(15.6%)

1.106

0.293

rest pain

25 (40.3%)

33(42.9%)

0.091

0.763

gangrene or tissue loss

23 (37.1%)

32(41.5%)

0.286

0.593

  1. Abbreviations: ABI, ankle brachial indexes